TELA Bio, Inc.

NASDAQ
TELA
paper.types.company
Rentabilité sur six mois: -53.8%
Rendement en dividendes: 0%
Secteur: Healthcare

1.4 $

-0.08 $ -5.41%
0.89 $
5.63 $

paper.min_max_per_year

Calendrier des promotions TELA Bio, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise TELA Bio, Inc.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy.

plus de détails
The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

IPO date
2019-11-08
ISIN
US8723811084
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 1.24 9
P/BV 3.03 5
P/E 0 0
Efficacité
Nom Signification Grade
ROA -45.97 0
ROE -159.87 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -1.32 10
Debt/Ratio 0.4813 10
Debt/Equity 2.04 6
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 280.77 10
Rentabilité Ebitda, % 25.73 4
Rentabilité EPS, % -46.08 0
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 1.48 $ 0 $ 0 $ -5.41 % 0 % 0 %
common.calendar.number_days.7d 1.39 $ 0 $ 0 $ 0.72 % 0 % 0 %
common.calendar.number_days.30d 0.9593 $ 0.98 $ 1.48 $ 45.94 % 0 % 0 %
common.calendar.number_days.90d 2.6 $ 0.89 $ 2.43 $ -46.15 % 0 % 0 %
common.calendar.number_days.180d 3.03 $ 0.89 $ 3.02 $ -53.8 % 0 % 0 %
common.calendar.number_days.1y 5.83 $ 0.89 $ 5.63 $ -75.99 % 0 % 0 %
common.calendar.number_days.3y 6.59 $ 0.89 $ 12.03 $ -78.76 % 0 % 0 %
common.calendar.number_days.5y 11.12 $ 0.89 $ 22.61 $ -87.41 % 0 % 0 %
common.calendar.number_days.10y 0 $ 0.89 $ 22.61 $ 0 % 0 % 0 %
common.calendar.number_days.ytd 2.85 $ 0.89 $ 2.91 $ -50.88 % 0 % 0 %

Principaux propriétaires

Contenu dans l'ETF

ETFPartager, %Rentabilité pour l'année, %Commission, %
Jacob Forward ETF 2.05852 43.03 0.75
2,0643,030,75

Entreprises similaires

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Antony Koblish Co-founder, President, CEO & Director 1.03M 1966 (59 années)
Mr. Roberto E. Cuca J.D. CFO & COO 674.78k 1968 (57 années)
Mr. Paul Talmo Chief Technology Officer 595.67k 1972 (53 année)
Ms. Megan Smeykal VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer N/A 1976 (49 années)
Mr. D. Taylor Ocasio General Counsel & Corporate Secretary N/A
Ms. Jennifer Lou Armstrong Senior Vice President of Human Resources N/A 1970 (55 années)
Mr. Gregory A. Firestone Chief Commercial Officer N/A 1959 (66 années)
Mr. Michael Leonard Senior Vice President of Technical Operations N/A
Mr. Peter C. Murphy Chief Commercial Officer 542.34k 1973 (52 année)
Louisa Smith Investor Relations Contact Officer N/A

Informations sur l'entreprise

Adresse: United States, Malvern. PA, 1 Great Valley Parkway - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.telabio.com